Systemic Vascular Resistance (SVR) represents the resistance to blood flow offered by the systemic vasculature. It is a critical hemodynamic parameter that reflects the afterload the heart must overcome to eject blood into the systemic circulation. This parameter is derived using the formula: Mean Arterial Pressure (MAP) minus Central Venous Pressure (CVP), divided by Cardiac Output (CO). The resulting value is then multiplied by a constant (usually 80) to express the resistance in dynessec/cm5. For instance, if a patient has a MAP of 85 mmHg, a CVP of 5 mmHg, and a CO of 5 L/min, the calculation would be (85-5)/5, multiplied by 80, yielding an SVR of 1280 dynessec/cm5.
Understanding and monitoring SVR provides valuable insights into a patient’s cardiovascular status. Elevations can indicate vasoconstriction, hypovolemia, or certain medications’ effects. Conversely, a decrease can signal vasodilation, sepsis, or the administration of vasodilating agents. Historically, accurate assessment of this resistance has been crucial in managing patients with conditions such as shock, heart failure, and hypertension, enabling clinicians to tailor treatments to optimize cardiac function and tissue perfusion. Accurate monitoring helps in the early identification of potential complications and facilitates timely intervention.